21:15 , May 18, 2018 |  BioCentury  |  Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
04:28 , Jan 27, 2017 |  BC Week In Review  |  Financial News

Atlas Genetics completes venture financing

Molecular diagnostics company Atlas Genetics Ltd. (Trowbridge, U.K.) raised $35 million in a series D round on Jan. 23. New investor Wondfo Biotech participated alongside existing investors Novartis Venture Funds, Consort Medical plc, the Johnson...
00:37 , Jan 24, 2017 |  BC Extra  |  Financial News

Atlas Genetics raises $35M in series D

Molecular diagnostics company Atlas Genetics Ltd. (Trowbridge, U.K.) raised $35 million in a series D round. New investor Wondfo Biotech participated alongside existing investors Novartis Venture Funds, Consort Medical plc (LSE:CSRT), the Johnson & Johnson...
08:00 , Feb 2, 2015 |  BC Week In Review  |  Financial News

Atlas Genetics completes venture financing

Atlas Genetics Ltd. , Trowbridge, U.K.   Business: Diagnostic   Date completed: 2015-01-29   Type: Venture financing   Raised: $20 million   Investors: RMI Partners; Novartis Venture Funds; Consort Medical plc ; Johnson & Johnson...
02:46 , Jan 30, 2015 |  BC Extra  |  Financial News

Atlas Genetics raises $20M in series C round

Diagnostics company Atlas Genetics Ltd. (Trowbridge, U.K.) raised $20 million in a series C round from new investor RMI Partners, a subsidiary of Rusnano, and existing investors Novartis Venture Funds; Consort Medical plc ; Johnson...
07:00 , Sep 15, 2014 |  BC Week In Review  |  Financial News

AM-Pharma completes venture financing

AM-Pharma B.V. , Bunnik, the Netherlands   Business: Renal, Autoimmune   Date completed: 2014-09-11   Type: Venture financing   Raised: EUR12.2 million ($15.8 million)   Investors: Gilde Healthcare Partners; AbbVie Inc. ; BB Biotech Ventures;...
01:33 , Sep 13, 2014 |  BC Extra  |  Financial News

AM-Pharma raises EUR 12.2M

AM-Pharma B.V. (Bunnik, The Netherlands) raised EUR 12.2 million ($15.8 million) in a tranched series E round led by Gilde Healthcare. Existing investors participating in the new round included the venture arm of AbbVie (NYSE:ABBV);...
07:00 , May 26, 2014 |  BioCentury  |  Finance

Europe's Iceberg 2014: Premier League teams

Competing in biotech's Premier League requires deep pockets, long term planning and the risk appetite to pursue novel technologies or targets that don't always pan out. BioCentury's 12th annual European Iceberg survey reveals that for...
07:00 , May 5, 2014 |  BC Week In Review  |  Financial News

Atlas Genetics financial update

The company raised an undisclosed amount in the third and final tranche of a series B round, bringing the total raised to £16.9 million ($28.5 million). Novartis Venture Funds; Consort Medical; LSP-Life Sciences Partners; BB...
07:00 , May 20, 2013 |  BioCentury  |  Finance

Merck Serono's earnest money

Four years after launching a strategic venture fund, the Merck Serono S.A. unit of Merck KGaA is making a long-term commitment with an infusion of €60 million ($77.8 million). While the fund's focus will remain...